International Journal of Eating Disorders

Cover image for Vol. 50 Issue 5

Edited By: Ruth Striegel Weissman

Impact Factor: 4.068

ISI Journal Citation Reports © Ranking: 2015: 10/122 (Psychology Clinical); 11/80 (Nutrition & Dietetics); 12/76 (Psychology); 18/139 (Psychiatry (Social Science)); 31/142 (Psychiatry)

Online ISSN: 1098-108X



Author Guidelines


GUIDELINE SECTIONS

  1. Submission
  2. Aims and Scope
  3. Manuscript Categories and Requirements
  4. Preparing the Submission
  5. Editorial Policies and Ethical Considerations
  6. Author Licensing
  7. Publication Process After Acceptance
  8. Post-Publication
  9. Editorial Office Contact Details

1. SUBMISSION


Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. If there is a related paper under consideration at another journal, a copy of that paper should be submitted with the primary manuscript as supporting information.

Authors should follow the guidelines carefully; failure to do so will delay the processing of the manuscript. Once the submission has been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at mc.manuscriptcentral.com/ijed. Authors unfamiliar with ScholarOne can find details on how to use the system here: www.wileyauthors.com/scholarone.

The submission system will prompt the author to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Details can be found elsewhere in these guidelines.

For help with submissions, authors should contact the Editorial Office: ijed@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editor-in-Chief or Associate Editors.

Return to Guideline Sections

2. AIMS AND SCOPE


The International Journal of Eating Disorders—A leading peer-reviewed journal in the fields of psychology, psychiatry, public health, and nutrition & dietetics.

Mission: With a mission to advance the scientific knowledge needed for understanding, treating, and preventing eating disorders, the International Journal of Eating Disorders publishes rigorously evaluated, high-quality contributions to an international readership of health professionals, clinicians, and scientists. The journal also draws the interest of patient groups and advocates focused on eating disorders, and many of the articles draw attention from mainstream media outlets.

Scope: Articles featured in the journal describe state-of-the-art scientific research on theory, methodology, etiology, clinical practice, and policy related to eating disorders, as well as contributions that facilitate scholarly critique and discussion of science and practice in the field. Theoretical and empirical work on obesity or healthy eating falls within the journal’s scope inasmuch as it facilitates the advancement of efforts to describe and understand, prevent, or treat eating disorders. The International Journal of Eating Disorders welcomes submissions from all regions of the world and representing all levels of inquiry (including basic science, clinical trials, implementation research, and dissemination studies), and across a full range of scientific methods, disciplines, and approaches.

A complete overview of the journal is given elsewhere on the journal’s homepage.

Return to Guideline Sections

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


The International Journal of Eating Disorders publishes the following contribution types:

  1. Original Articles
  2. Brief Reports
  3. Clinical Case Reports
  4. Reviews
  5. An Idea Worth Researching
  6. Commentaries

When uploading their manuscript, authors will be asked to complete a checklist indicating that they have followed the Author Guidelines pertaining to the appropriate article type. All word limits relate to the body of the text (i.e., not including abstract, references, tables and figures) and represent maximum lengths. Authors are encouraged to keep their manuscript as short as possible while communicating clearly.

1)      Original Articles

These contributions report substantive research that is novel, definitive, or complex enough to require a longer communication. Only a subset of research papers is expected to warrant full-length format.

  • Word Limit: 4,500 (excluding abstract, references, tables or figures)
  • Abstract: 250 words.
  • References: 60 are recommended; more are permissible, for cause.
  • Figures/Tables: a maximum of 8 essential tables/figures, overall.

When preparing their manuscript, authors should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58). When preparing the Methods section, authors should refer to the Editorial Policy on Sample Size and Statistics.

2)      Brief Reports.

This contribution type is intended for manuscripts describing studies with straightforward research designs, pilot or “proof of concept” studies, and replications.

  • Word Limit: 2,000 (excluding abstract, references, tables or figures).
  • Abstract: 200 words.
  • References: 20 are recommended; more are permissible, for cause.
  • Figures/Tables: a maximum of 2 essential tables/figures, overall.

As for Original Articles, when preparing their manuscript, authors should follow the IMRaD guidelines and comply with the Editorial Policy on Sample Size and Statistics.

 

3)      Clinical Case Reports.

Clinical Case Reports detail key elements of cases where there is novelty in the presentation, pathology or treatment, and where that novelty will inform clinicians and researchers about rare presentations or novel ideas. This category will often be appropriate to rare biological or psychological presentations. Reports of rigorously conducted studies employing single-case experimental designs are especially welcome.

Every effort should be taken to ensure the anonymity of the patient concerned, and any clinicians not involved as authors. If there is any potentially identifiable information, then it is the responsibility of the authors to obtain approval from the local Institutional Review Board (IRB) (or equivalent) for the case to be reported, and a copy of that approval should be made available to the Editor on request.

  • Word Limit: 2,000 (excluding abstract, references, tables or figures).
  • Abstract: 150 words.
  • References: 20.
  • Figures/Tables: a maximum of 2 essential tables/figures, overall.

4)      Reviews.

These articles critically review the status of a given research area and propose new directions for research and/or practice. Both systematic and meta-analytic review papers are welcomed if they review a literature that is advanced and/or developed to the point of warranting a review and synthesis of existing studies. Reviews of topics with a limited number of studies are unlikely to be deemed as substantive enough for a Review paper. The journal does not accept papers that merely describe or compile a list of previous studies without a critical synthesis of the literature that moves the field the forward.

  • Word Limit: 7,500 (excluding abstract, references, tables or figures).
  • Abstract: 250 words.
  • References: 100.
  • Figures/Tables: no maximum, but should be appropriate to the material covered.

All Review articles must follow the PRISMA Guidelines ( www.prisma-statement.org ), summarized in a 2009 J. Clin. Epidemiol. article by Moher et al. entitled “Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement” (DOI: 10.1016/j.jclinepi.2009.06.005), freely available for download in both English and Spanish.

Authors who choose this contribution type must complete the Review Checklist upon submission of the manuscript, an example of which can be found here). This example is for informational purposes only. During the submission process, authors will be prompted to complete the Review Checklist directly in ScholarOne. The rationale for any unchecked items on the Review Checklist must be explicitly described in the accompanying Cover Letter.

5)      An Idea Worth Researching

This is a contribution type where authors propose an idea that may not yet have adequate empirical support or be ready for full empirical testing, but holds great promise for advancing research of eating disorders. Authors are encouraged to write a piece that is bold, forward looking, and suggestive of new and exciting avenues for research and/or practice in the field.

  • Word Limit: 2,000 (excluding abstract, references, tables or figures).
  • Abstract: 200 words.
  • References: 20 recommended (more permitted, for cause).
  • Figures/Tables: a maximum of 2 essential tables/figures, overall.

6)      Commentaries

Commentaries are solicited by the Editors when multiple perspectives on or critical appraisal of an article would assist in placing that article in context. Unsolicited commentaries are not considered for publication.

  • Word Limit: 2,000 (excluding abstract, references, tables or figures).
  • Abstract: no abstract.
  • References: 5, using the footnote format rather than the journal’s standard format.
  • Figures/Tables: none.

Return to Guideline Sections

4. PREPARING THE SUBMISSION


Parts of the Manuscript

The submission should be uploaded in separate files: 1)manuscript file; 2) figures;3) Supporting Information file(s).

1. Manuscript File

The text file should contain all of the manuscript text, including the tables and figure legends. The text should be presented in the following order:

  1. Title
  2. A short running title of less than 40 characters
  3. The full names of all authors
  4. The authors' institutional affiliations where the work was conducted, with a footnote for an author’s present address if different to where the work was carried out
  5. Acknowledgements
  6. Abstract and Keywords
  7. Main text
  8. References
  9. Tables (each table complete with title and footnotes)
  10. Figure legends

Title

The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).

Authorship

For details on eligibility for author listing, please refer to the journal’s Authorship policy outlined in Section 5 of these Author Guidelines.

Acknowledgments

Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. See the journal’s policy on Conflict of Interest outlined in Section 5 of these Author Guidelines. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

The word maximum and abstract format varies by contribution type (see above). When an abstract is required, the abstract should be typed as a single paragraph. The journal requires structured abstracts with two exceptions: the journal will continue to use unstructured abstracts for Clinical Case Reports and "An Idea Worth Researching".

Structured abstracts should be organized as follows: Objective: briefly indicate the primary purpose of the article, or major question addressed in the study. Method: indicate the sources of data, give brief overview of methodology, or, if review article, how the literature was searched and articles selected for discussion. For research based articles, this section should briefly note study design, how participants were selected, and major study measures. Results: summarize the key findings. Discussion: indicate main clinical, theoretical, or research applications/implications.

Keywords

Please provide five to seven keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.

Main Text

  • Authors should refrain from using terms that are stigmatizing or terms that are ambiguous. For further explanation and examples, see the 2016 IJED article by Weissman et al. entitled "Speaking of that: Terms to avoid or reconsider in the eating disorders field" (DOI: 10.1002/eat.22528.
  • The text should be divided as outlined in Section 3 “Manuscript Categories and Requirements”.
  • Manuscripts reporting original research should follow the IMRaD guidelines (Introduction, (Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58).
  • To facilitate evaluation by the Editors and Reviewers, each manuscript page should be numbered; and line numbers should be applied (restarting from 1 on each page). Instructions on how to implement this feature in Microsoft Word are given here.
  • The journal uses US spelling. Authors may submit using any form of English as the spelling of accepted papers is converted to US English during the production process.
  • Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
  • It is the primary responsibility of the authors to proofread thoroughly and ensure correct spelling and punctuation, completeness and accuracy of references, clarity of expression, thoughtful construction of sentences, and legible appearance prior to the manuscript's submission.
  • Authors for whom English is not their first language are encouraged to seek assistance from a native or fluent English speaker to proof read the manuscript prior to submission. Wiley offers a paid service that provides expert help in English language editing—further details are given below.
  • Articles reporting data taken from or deposited elsewhere should refer to the journal policy on Data Storage and Documentation in Section 5 (below).

References

References in all manuscripts should follow the style of the American Psychological Association (6th edition), except in regards to spelling. The APA website includes a range of resources for authors learning to write in APA style, including An overview of the Publication Manual of the American Psychological Association, Sixth Edition; includes free tutorials on APA Style basics and an APA Style Blog. Please note APA referencing style requires that a Digital Object Identifier (DOI) be provided for all references where available.

Tables

Each table must be numbered in order of appearance in the text with Arabic numerals and be cited at an appropriate point in the text. Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files (i.e., created in Microsoft Word or similar), not pasted as images. Legends should be concise but comprehensive—the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as standard deviation (SD) or standard error of the mean (SEM) should be identified in the headings. The journal’s Editorial Policy on Sample Size and Statistics is given in Section 5.

Figure Legends/Captions

Each figure caption should have a brief title that describes the entire figure without citing specific panels, followed by a description of each panel. Captions should be concise but comprehensive—the figure and its caption must be understandable without reference to the text. Be sure to explain abbreviations in figures even if they have already been explained in-text. Axes for figures must be labeled with appropriate units of measurement and description. Include definitions of any symbols used and units of measurement.

2. Figures

Although authors are encouraged to send the highest quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Helvetica typeface is preferred for lettering within figures. All letters, numbers and symbols must be at least 2 mm in height. Courier typeface should be used for sequence figures. Figures should be numbered consecutively with Arabic numerals, and they should be numbered in the order in which they appear in the text.

Figures should be submitted as electronic images to fit either one (55 mm, 2 3/16”, 13 picas), two (115 mm, 4 1/2”, 27 picas), or three (175 mm, 6 7/8”, 41 picas) columns. The length of an illustration cannot exceed 227 mm (9”). Journal quality reproduction requires grey scale and color files at resolutions of 300 dpi. Bitmapped line art should be submitted at resolutions of 600–1200 dpi.

Figures submitted in color will be reproduced in color online free of charge. Authors wishing to have figures printed in color in hard copies of the journal will be charged a fee by the Publisher; further details are given elsewhere in these Author Guidelines. Authors should note however, that it is preferable that line figures (e.g., graphs) are supplied in black and white so that they are legible if printed by a reader in black and white.

3. Supporting Information Files(s)

Supporting information is information that is not essential to the article, but provides greater depth and background. If an article is accepted for publication, the Supporting Information is hosted online together with the article and appears without editing or typesetting. It may include, but is not limited to, video clips, large sections of tabular data, program code, or electronic graphical files that are otherwise not suitable inclusion in the main article. Click here for Wiley’s FAQs on Supporting Information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

Supporting Information must be submitted at the time of peer review. The availability of this material should be indicated in the text of the article where appropriate.

General Style Points

The following points provide general advice on formatting and style.

  • Terminology: Terms such as “anorexics” or “bulimics” as personal pronouns, referring to groups of individuals by their common diagnosis, should be avoided. Terms like “individuals with anorexia nervosa”, “people with bulimia nervosa”, or “participants with eating disorders” should be used instead. Note, “participants” should be used in place of “subjects”.
  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.
  • Numbers under 10 should be spelt out, except for: measurements with a unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • The word “data” is plural; therefore, text should follow accordingly (for example, “The data show…the data are … the data were…”).
  • Sex/Gender & Age: When referring to sex/gender, “males" and “females” should be used only in cases where the study samples include both children (below age 18) and adults and only if word limit precludes using terms such as “male participants/female participants,” “female patients/male patients”; when the participants comprise adults only, the terms “men” and “women” should be used. In articles that refer to children, “boys” and “girls” should be used.
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
  • Statistics: Authors should adhere to the journal’s policy on Sample Size and Statistics when reporting studies. For information on how to present p values and other standard measurements see IJED Statistical Formatting Requirements.

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.

Return to Guideline Sections

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Editorial Review and Acceptance

Rigorous evaluation of submitted material by expert reviewers is essential to ensuring that the journal achieves its mission. To facilitate timely feedback to authors and to avoid burdening expert reviewers unduly, the journal utilizes a two-tiered review process for all contributions (whether invited or unsolicited). The first tier involves an initial editorial preview to be implemented within days of receipt of a submission. If the manuscript is considered to have potential for publication in the journal, the second tier involves peer review, typically by two to three experts. The Editor-in-Chief, at times, may delegate final decision making authority to one of the Associate Editors.

Editorial Pre-Screen. The Editor-in-Chief will pre-screen all submissions to determine the suitability based on fit with the journal’s scope and scholarly merit. Manuscripts deemed to fall outside of the journal’s scope or to be of limited merit (e.g., because of substantial methodological flaws or insufficiently novel contribution to the field) will not be sent out for peer review. Pre-screening of articles does not involve detailed evaluation.

Peer Review. Submissions that, based on editorial pre-screening, are considered of potential suitability for the journal are forwarded to experts in the field—ad hoc reviewers or members of the journal’s Editorial Board—for detailed evaluation and feedback. Expert reviewers are asked to evaluate the merit of a manuscript based on the quality of the methods applied, presentation, and overall contribution to the field. Reviewers are instructed to offer a thorough, constructive, and timely evaluation of all aspects of the submission and to enumerate strengths and weaknesses. Authors are invited to recommend expert reviewers.

Exceptions to the peer-review procedures described above: Commentaries are evaluated only by the Editor handling the submission and one additional reviewer.

Wiley's policy on confidentiality of the review process is available here: www.wileypeerreview.com/reviewpolicy.

Transferable Peer Review. To enable rapid publication of good quality research that is unable to be accepted for publication by the International Journal of Eating Disorders, we work together with Wiley's Open Access journal: Health Science Reports. Authors may be offered the option of having their manuscript (inc. any Supporting Information), along with any related peer reviews, automatically transferred for consideration by the Editor of Health Science Reports. Authors taking up the offer to transfer will not need to reformat or rewrite their manuscript at that stage, and a publication decision will be made a short time after the transfer has taken place. The Editor of Health Science Reports will accept submissions that report well-conducted research that reaches the standard acceptable for publication. Health Science Reports is part of the Wiley Open Access portfolio (www.wileyopenaccess.com), and thus Article Publication Fees apply. For more information, please go to the journal homepage: onlinelibrary.wiley.com/journal/10.1002/(ISSN)2398-8835.

Editorial Policy on Sample Size and Statistics

The Methods section should include a statement about sample selection, response rate, and other factors that would impact selection or response bias and, in turn, representativeness of the sample. Inclusion of small samples requires justification and authors should be mindful of the recommendations concerning minimal sample sizes in subfields (e.g., genetic research, instrument development, etc., where adequate samples may number in the hundreds). Authors also are asked to provide information about reliability and validity of study measures as applicable to their sample.

If the study involves qualitative data, authors need to include a statement about sample size in relation to theme saturation. We recommend that authors review the BMJ checklist for studies involving qualitative methods and conduct and report their analyses accordingly.

If the work involves cross-cultural assessment or assessment in a new language or study population, authors should provide information about local literacy in the language of assessment, the validity of (or process for validating) a translation of an assessment, and for inclusion of regional samples, a statement about the representativeness of the regional sample (or distinction from) the national sample. If statistical analyses are employed, effect size estimates should be reported in the Results section.

For additional detail regarding statistical requirements for the manuscript, see IJED Statistical Formatting Requirements. For more detailed background information on statistical analyses and their rationale authors are referred to IJED Statistical Reporting Guidelines .

Manuscripts reporting statistical tests without effect size estimates may be rejected without review.

Guidelines for Genetic Studies

Authors of manuscripts describing association studies should note that the International Journal of Eating Disorders has adopted Methods guidelines developed and published by the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. These guidelines recommend minimum sample sizes; in the case of positive findings, an adequately powered independent replication sample; and adjustments for multiple comparisons. As is required for all papers, the guidelines also require that authors report effect size estimates. For a complete description, please refer to the AJMGB Editorial Policy on Association Studies described in their Author Guidelines.

Please note, when referring to genetic material, the names of genes should be spelled out in full the first time they appear in the text, after which an italicized abbreviation can be substituted. Sequence variants should be described in the text and tables using both DNA and designations whenever appropriate. Sequence variant nomenclature must follow the current Human Genome Variation Society (HGVS) guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Data Storage and Documentation

The International Journal of Eating Disorders encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts, and other artefacts used to generate the analyses presented in the paper available via a publicly available data repository; however, this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Human Studies and Subjects

For manuscripts reporting studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects ; or European Medicines Agency Guidelines for Good Clinical Practice.

Every effort should be taken to ensure the anonymity of the patient concerned, and any clinicians not involved as authors. If there is any potentially identifiable information, then it is the responsibility of the authors to seek and obtain approval from the local Institutional Review Board (IRB) (or equivalent) for the case to be reported, and a copy of that approval should be made available to the Editor on request.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval (e.g., in the USA, the Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC)), must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers are included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the Abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to any research reporting standards relevant to their study. A list of the most well-known guidelines is given here:

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence datashould be submitted to either of the following repositories.

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript.

Potential sources of conflict of interest include, but are not limited to: employment at a for-profit treatment center where data collection occurred, employment at a for-profit corporation if the corporation manufactures or sells products used in the research (e.g., medications; equipment used in a treatment tested as part of the research), patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company.

The existence of a conflict of interest does not preclude publication. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships. These conflicts of interest should be disclosed in the relevant section of the submission questionnaire and in the manuscript. If the authors have no conflict(s) of interest to declare, they must also state this.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: www.crossref.org/services/funder-registry.

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. If the submitting author is not already registered with ORCID, they can do so here: orcid.org/register; this takes around 2 minutes to complete. For more information, visit www.wileyauthors.com/orcid.

Publication Ethics

The International Journal of Eating Disorders is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read the Top 10 Publishing Ethics Tips for Authors at www.wileyauthors.com/ethics ; a link to Wiley’s Publication Ethics Guidelines can also be found there.

Return to the Guideline Sections

6. AUTHOR LICENSING


If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or OnlineOpen under the terms of a Creative Commons (CC) License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; the Wiley Author Compliance Tool, available at www.wileyauthors.com/compliancetool, provides assistance to authors in checking for any open-access mandates from their funder(s).)

Self-Archiving Definitions and Policies

Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. For more detailed information about self-archiving definitions and policies, visit www.wileyauthors.com/self-archiving.

Open Access Fees

Authors choosing to publish using OnlineOpen will be charged a fee. A list of Article Publication Charges for Wiley journals is available at www.wileyauthors.com/APCpricing.

Funder Open Access

For more information on Wiley’s compliance with the open-access policies of specific funders, visit www.wileyauthors.com/funderagreements.

Return to Guideline Sections

7. PUBLICATION PROCESS AFTER ACCEPTANCE


Accepted Articles Received in Production

Signing the License

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services . The author will be asked to sign a publication license at this point. Further details are given in Section 6 of these Author Guidelines.

Proofs

Once the paper is typeset, the author will receive an email notification with the URL to download a PDF typeset page proof, as well as associated forms and full instructions on how to correct and return the file.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process—authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt.

Questions regarding the production of articles accepted for publication in the International Journal of Eating Disorders should be directed to the Production Editor: eat@wiley.com

Publication Charges

There are no mandatory charges to authors publishing in the International Journal of Eating Disorders.

Authors may choose to publish in an open access format through OnlineOpen, which carries a fee (see the section on Author Licensing.

Color figures may be published online free of charge; however, the International Journal of Eating Disorders charges for publishing figures in color in print. If an author supplies color figures, they will be sent a Color Work Agreement (aka, Color Charge Form) once the accepted paper moves in to the production process. If the Color Work Agreement is not returned by the specified date, figures will be converted to black and white for print publication.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as the proofs need to be reviewed and processed. Once the article is published on Early View, no further changes are possible. The Early View article is fully citable and carries an online publication date and Digital Object Identifier (DOI) for citations.

Video Abstracts

A video abstract can be a quick way to make the message of your research accessible to a much larger audience. Wiley and its partner Research Square offer a service of professionally produced video abstracts, available to authors of articles accepted in this journal. You can learn more about it at www.wileyauthors.com/videoabstracts. If you have any questions, please direct them to videoabstracts@wiley.com.

Return to Guideline Sections

8. POST PUBLICATION


Access and Sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Authors may order print copies of the article. Instructions are sent at proofing stage. Alternatively, authors may use the following link: caesar.sheridan.com/reprints/redir.php?pub=10089&acro=eat or email chris.jones@sheridan.com.

Promoting an Article

Wiley’s Promotional Toolkit is a resource designed to help authors disseminate their work to the fullest extent through their networks and beyond. Authors can find the toolkit and other ideas on how to promote their research here: www.wileyauthors.com/maximize.

Authors intending to issue a press release through their institution or affiliation are kindly asked to inform the Editorial Office at their earliest convenience.

Measuring the Impact of an Article

Wiley also helps our authors measure the impact of their research through citation tracking, and specialist partnerships with Kudos (www.wileyauthors.com/ kudos ) and Altmetric ( http://www.wileyauthors.com/altmetric ).

Author queries regarding submissions under review or accepted articles in production should be directed to the Editorial Office ( ijed@wiley.com) or Production Editor (( EAT@wiley.com), respectively. A complete list of contacts for International Journal of Eating Disorders is available on the journal’s contacts page.

Author Guidelines updated April 10, 2017

SEARCH

SEARCH BY CITATION